Therefore, our work also provides a clear mechanistic understanding of vinorelbine-induced peripheral neuropathy and leads us to the third conclusion that MNK signaling is a therapeutic avenue for reducing the neuropathy caused by this chemotherapeutic. This evidence concerns the gene ATP7A and peripheral neuropathy.